Ongoing clinical trials in molecular imaging and radiotheranostics. Sorted by date of last update.
Evaluation of the I-phase Clinical Trial of Lu-177-HX02 Injection in Patients with Advanced Malignant Solid Tumors
Phase 1
Last update: November 6
Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Lu-177 Radiolabeled Monoclonal Antibody HuJ591 (Lu-177-J591) and Ketoconazole in Patients with Prostate Cancer
Phase 2
Last update: November 5
Repurposing Tilmanocept for Cardiac Sarcoidosis
Flutemetamol F 18 Injection Formulation Comparison
Testing Lutetium Lu-177 Dotatate in Patients with Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
Characterizing Tumor Hypoxia with BOLD-MRI to Predict Y-90 Treatment Response (BOLDMRI)
N/A
Last update: November 4
Lu-177-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer (PSMAfore)
Phase 3
A Study of Lu-177-DTPA-SC16.56 in People with Neuroendocrine Carcinomas of the Lung and Prostate
Positron Emission Tomography in Women with Advanced HER2-Positive Breast Cancer